The urban air mobility company’s shares fell 1.6% following the earnings release as investors reacted to the earnings miss. The company reported an adjusted EBITDA loss of $118.7 million for the ...

Investing.com -- Septerna, Inc. (NASDAQ: SEPN ), a biotechnology company focused on G protein-coupled receptor (GPCR) drug discovery, saw its shares fall 4.3% after reporting a widened net loss for ...

OVERLAND PARK, Kan. - Compass Minerals (NYSE: CMP) reported better-than-expected revenue for its fiscal 2025 third quarter, though earnings fell short of analyst expectations. The essential minerals ...

The company reported an adjusted EBITDA of $17.2 million, up 6.2% from $16.2 million in the second quarter of 2024, despite the revenue decline. RumbleOn also reduced its selling, general and ...

Investing.com -- Eastman Kodak Company (NYSE: KODK) shares tumbled 10% after the company reported a significant earnings decline, swinging to a net loss in the second quarter of 2025 as it continues ...

Investing.com -- BigBear.ai Holdings, Inc. (NYSE: BBAI) shares tumbled 21.6% after the AI-powered decision intelligence solutions provider reported second-quarter results that missed analyst ...

Investors reacted negatively to Celanese’s third-quarter outlook, which projects adjusted earnings per share between $1.10 and $1.40, significantly below the analyst consensus of $1.73. The company ...

Investing.com -- AST SpaceMobile Inc on Tuesday reported a wider second-quarter loss and revenue well below Wall Street estimates, as the satellite communications company ramped up spending to build ...

Investor sentiment turned positive following the results, with shares moving higher in after-hours trading. With a $15.7 ...

The media company posted revenue of $933.7 million for the quarter ended June 30, 2025, surpassing the consensus estimate of $912.4 million and representing a 0.5% increase YoY. Adjusted EBITDA rose 3 ...

SAN DIEGO - Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) reported a significant revenue shortfall in the second quarter as the company continues to advance its pipeline of mRNA therapeutics and ...

Fourth-quarter adjusted EBITDA reached $51.3 million with an 18.8% margin, while free cash flow was $34.0 million. For the full fiscal year 2025, Mercury reported revenue of $912.0 million, up 9.2% ...